Associated Papers
Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies.
Almomani R et al.
International Journal of Molecular Sciences, 2023
37175987 (PubMed )
Supplement: ijms-24-08278-s001.zip › ijms-2239683-supplementary.pdf
Inhibition of the Human Neuronal Sodium Channel Nav1.9 by Arachidonyl-2-Chloroethylamide, An Analogue of Anandamide in a hNav1.9/rNav1.4 Chimera, An Experimental and in Silico Study.
Marchese-Rojas M et al.
Neuroscience, 2023
SCN11A Arg225Cys mutation causes nociceptive pain without detectable peripheral nerve pathology.
Castoro R et al.
Neurology. Genetics, 2018
Electrophysiological and Pharmacological Analyses of Nav1.9 Voltage-Gated Sodium Channel by Establishing a Heterologous Expression System.
Zhou X et al.
Frontiers in Pharmacology, 2017
Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9.
Phatarakijnirund V et al.
Bone, 2016
NaV1.9: a sodium channel linked to human pain.
Dib-Hajj SD et al.
Nature Reviews. Neuroscience, 2015
Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy.
Huang J et al.
Brain : a Journal of Neurology, 2014
Select a paper to view details